Don Hardison brings more than 40 years of executive leadership experience in emerging and Fortune 500 diagnostics, biotechnology, and life sciences companies. He was President, CEO, and Director of Biotheranostics, Inc. prior to its acquisition by Hologic. Prior to that, he served as President, CEO, and Director of Good Start Genetics, Inc., a leading molecular diagnostics and information company, specializing in genetic screening for inherited disorders utilizing a proprietary next-generation sequencing platform.
Mr. Hardison was an Executive Vice President & Chief Operating Officer at Laboratory Corporation of America Holdings (NYSE: LH), and President, CEO, and Director of EXACT Sciences Corporation (NASDAQ: EXAS). Prior to that, he worked as a Managing Partner of OnTarget, a sales and marketing consulting firm, and held leadership roles at Quest Diagnostics and SmithKline Beecham Corporation. He currently serves on the boards of YourBio Health, Geneoscopy, HTG Molecular and Decode Health.
Mr. Hardison holds a BA in Political Science from the University of North Carolina, Chapel Hill.
Back to Our Team